Skip to main content
. 2019 Jun 21;104(11):5225–5237. doi: 10.1210/jc.2019-00461

Table 1.

Demographic and Clinical Characteristics of the Study Cohort

Total (n = 233) Individuals With VAT Data (n = 209) Individuals With SAT Data (n = 125) Individuals With VAT, SAT, and CT Data (n = 72)
Sex, n (%)
 Women 82 (35) 78 (32) 36 (29) 22 (31)
 Men 151 (65) 131 (68) 89 (71) 50 (69)
Age, y 63 (56–72) 64 (55–72) 63 (55–70) 64 (54–70)
BMI, kg/m2 26.1 (23.7–29.2) 26.1 (23.7–29.2) 26.6 (24.3–30.3) 26.4 (24.2–28.8)
VFA, cm2 167 (116–236) 165 (110–232) 175 (117–251) 182 (116–253)
SFA, cm2 206 (159–255) 206 (158–256) 209 (162–255) 203 (161–255)
CT scan availability, n (%) 153 (66) 137 (66) 91 (73) 72 (100)
Weight change within 1 y before surgery (%) −2.4 (−6.7 to 0) −2.4 (−6.7 to 0) −1.1 (−6.7 to 0) −3.0 (−6.7 to 0)
Weight change, data availability, n (%) 209 (90) 189 (90) 112 (90) 65 (90)
Tumor site, n (%)
 Colon 108 (46) 100 (48) 54 (43) 33 (46)
 Rectum 125 (54) 109 (52) 71 (57) 39 (54)
Tumor stage, n (%)
 I 38 (16) 32 (15) 17 (14) 8 (11)
 II 77 (33) 70 (33) 37 (30) 23 (32)
 III 65 (28) 59 (28) 37 (30) 24 (33)
 IV 45 (19) 41 (20) 27 (22) 17 (24)
Carcinoma in situ or no malignancy 8 (3) 7 (3) 7 (6) 0
Neoadjuvant therapy, n (%)
 Yes 74 (32) 64 (31) 44 (35) 25 (35)
 No 159 (68) 145 (69) 81 (65) 47 (65)

Data presented as median (interquartile range) for continuous variables and frequency (percentage) for categorical variables.